Article
Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells
30 Mar 2013
Abstract excerpt
Genomic instability is a hallmark of chronic myeloid leukemia in chronic phase (CML-CP) resulting in BCR-ABL1 mutations encoding resistance to tyrosine kinase inhibitors (TKIs) and/or additional chromosomal aberrations leading to disease relapse and/or malignant progression. TKI-naive and TKI-treated leukemia stem cells (LSCs) and leukemia progenitor cells (LPCs) accumulate high levels of reactive oxygen species...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
